No Data
908 Devices Inc. (NASDAQ:MASS) Is Favoured by Institutional Owners Who Hold 57% of the Company
908 Devices to Participate in Craig-Hallum Bioprocessing Conference
908 Devices Updates Investors With New Presentation
The Price Is Right For 908 Devices Inc. (NASDAQ:MASS) Even After Diving 29%
Buy Rating Affirmed for 908 Devices on Strong Market Position and Growth Prospects
TD Cowen Maintains 908 Devices(MASS.US) With Buy Rating
TD Cowen analyst Steven Mah maintains $908 Devices(MASS.US)$ with a buy rating.According to TipRanks data, the analyst has a success rate of 27.4% and a total average return of -10.9% over the past